Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medical Data Vision Co's EBIT per Share for the
six
months ended in Dec. 2025 was 円9.36.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was 円9.23.
During the past 12 months, the average EBIT per Share Growth Rate of Medical Data Vision Co was 9224.20% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -41.40% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -49.30% per year.
During the past 10 years, the average EBIT per Share Growth Rate was -8.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Medical Data Vision Co's EBIT per Share or its related term are showing as below:
TSE:3902'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -86.5 Med: 19.4 Max: 66.7
Current: -41.4
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Medical Data Vision Co was 66.70% per year. The lowest was -86.50% per year. And the median was 19.40% per year.
TSE:3902's 3-Year EBIT Growth Rate is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 11.7
vs TSE:3902: -41.40
Medical Data Vision Co (TSE:3902) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Medical Data Vision Co EBIT per Share Related Terms
Medical Data Vision Co EBIT per Share Historical Data
* Premium members only.
The historical data trend for Medical Data Vision Co's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円9.23
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Data Vision Co (TSE:3902) has a EBIT per Share of 円9.23 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Medical Data Vision Co and its competitors.
Is Medical Data Vision Co's EBIT per Share too high?
Medical Data Vision Co's current EBIT per Share is 円9.23. Overall, Medical Data Vision Co has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Medical Data Vision Co's EBIT per Share compare to VEEV and TEM?
Medical Data Vision Co's EBIT per Share of 円9.23 can be compared against companies in the Healthcare Providers & Services industry. The industry median EBIT per Share is 11.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.70, based on 521 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Medical Data Vision Co and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Data Vision Co's current EBIT per Share is 円9.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Data Vision Co stock overvalued right now?
Medical Data Vision Co (TSE:3902) has a current EBIT per Share of 円9.23. The stock's GF Value™ is 円657.61, compared to a current price of 円1,684.00 — trading 156.1% above its estimated fair value. The current EBIT per Share is 円9.23. Medical Data Vision Co's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Medical Data Vision Co (TSE:3902), the current EBIT per Share is 円9.23 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Data Vision Co (TSE:3902) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Data Vision Co stock appears to be overvalued.
The current stock price of 円1,684.00 is trading 156.1% above its estimated GF Value™ of 円657.61.
Key valuation signals for TSE:3902:
EBIT per Share: 円9.23
GF Value™: 円657.61 vs. price of 円1,684.00 (156.1% above fair value)
No single metric tells the full story. See the TSE:3902 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Data Vision Co Ltd provides health information services. The company is engaged in Development, production, sales, Maintenance work of medical information integration system, Analysis, survey and consulting of various medical data, Planning, design, development, and operation of the portal site. Its products include Calteco that allows patients to store and view a part of clinical information themselves and CADA payment service such as medical expenses postpay service that patients can freely set payment terms. Medical Code is a system that utilizes standard format data such as hospitalized outpatient EF and electronic reception data in DPC format to support solving various management problems and other related products.
56GF Score
Get the complete analysis for TSE:3902
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3902 has been successfully added to your 
